CGOV Asset Management’s Novartis NVS Stock Holding History

CGOV Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$70.7M	Sell	976,498 -25,460	-3%	-$1.94M	4.08%	12
2017 Q4	$94.4M	Buy	1,001,958 +25,936	+3%	+$1.96M	3.56%	14
2017 Q3	$93.9M	Buy	976,022 +12,445	+1%	+$940K	3.68%	14
2017 Q2	$93.6M	Sell	963,577 -149,255	-13%	-$10.6M	3.75%	13
2017 Q1	$98.7M	Buy	1,112,832 +27,264	+3%	+$1.82M	3.61%	13
2016 Q4	$95.1M	Buy	1,085,568 +195,003	+22%	+$12.6M	3.51%	13
2016 Q3	$82.7M	Buy	+890,565	New	+$64.9M	3.19%	13

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CGOV Asset Management's NVS Position: Q1 2018 in Review

CGOV Asset Management reduced its Novartis (NVS) stake by 2.5% in Q1 2018, selling an estimated $1.94M and leaving 976,498 shares worth $70.7M. The position accounts for 4.08% of the portfolio, ranked #12.

CGOV Asset Management first reported a position in NVS in Q3 2016 and has held it in 7 quarters since. The position peaked at $98.7M in Q1 2017. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

CGOV Asset Management held 976,498 shares of Novartis worth $70.7M as of Q1 2018.
CGOV Asset Management sold 25,460 Novartis shares in Q1 2018, an estimated $1.94M.
Novartis made up 4.08% of CGOV Asset Management's portfolio in Q1 2018, its #12 holding.
CGOV Asset Management first reported a position in Novartis in Q3 2016 and has held it in 7 quarters since.
CGOV Asset Management's Novartis position peaked at $98.7M in Q1 2017.
1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on CGOV Asset Management's 13F filing for Q1 2018, filed 9 Apr 2018.